最新的帖子

八月 06, 2020

West's Integrated Solutions - Reducing Risks

In 2011, the US FDA issued an advisory regarding the potential formation of glass lamellae in vials containing injectable drugs. This was in response to several drug recalls in 2010-11. The number of glass-related drug recalls has since declined greatly. This no doubt is due to key actions taken by pharmaceutical manufacturers before the drug goes to market, even during the development phases.
JiaMin Boo

Jia Min Boo

Technical Account Specialist, TCS, Jurong

Categories

Search the Blog

Archive